Latest Distribution Channels News

The Calmer Co. has locked in an exclusive global distribution agreement for its kava extract ingredients, underpinning a potential A$25 million revenue stream over three years across key markets including the US and ASEAN.

Murray Cod Australia (ASX:MCA) reported a 53% jump in FY26 sales volumes and a 17.9% rise in customer receipts, underpinned by new retail deals with Coles and Woolworths and a focused cost-cutting program.

Unith Ltd boosted its AI digital human platform with ISO/IEC 27001:2022 certification, launched new SDKs, and secured $2.75 million in fresh capital to fuel growth and commercial expansion.

Xenitra Limited (ASX:XEN) has turned around its cash flow in Q4 FY26, reporting positive operating cash flow of A$0.8 million driven by a leaner cost base and a shift towards higher-margin OTC medicines and blockchain-enabled OPAL tokenised sales.

N1 Holdings delivered a record quarter for settlement volumes and cash receipts despite a tough interest rate environment, driving a 10% rise in FY26 revenue to $21.67 million and $1.21 million net profit before tax.

OMG Group delivered a near 50% jump in FY26 net sales, expanding its product range nationally and breaking into international markets with new distribution agreements.

Wisr has reported its first full-year Cash NPAT profit of $1.0 million in FY26, driven by record loan originations and improved credit metrics, while lifting FY27 guidance to at least $5.0 million.

ECS Botanics plans to introduce two 2g all-in-one vape products under its OzSun brand in mid-August 2026, expanding its higher-margin B2C portfolio with a capital-efficient supply model.

Axtec has secured a strategic partnership with MRI Software to integrate its full product suite into widely used Australian real estate software, opening a major distribution channel across agent networks nationwide.

Monvia Limited, an Australian SaaS provider for life insurers, is seeking to raise $17.5 million via an IPO on the ASX. The funds will support redemption of preference shares and fuel growth in existing and new markets.

Proteomics International has locked in a three-year exclusive distribution deal with Healius, leveraging its extensive pathology network to roll out its Promarker® diagnostic tests nationally from FY27.

WhiteHawk Limited has appointed Adrian Vallino as Group CEO to spearhead its global expansion and commercialisation of the Quixxi Clarity AI platform, aiming to grow recurring revenue and diversify its distribution channels.